Status:
COMPLETED
Beginning Early and Assertive Treatment for Methamphetamine Use Disorder
Lead Sponsor:
Denver Health and Hospital Authority
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Methamphetamine Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall goal of the study is to evaluate the effectiveness of a secondary prevention strategy implemented at a systems-level to prevent stimulant related overdoses.
Detailed Description
To date, a public health systems approach to enhance linkage and engagement in care for stimulant use disorders is lacking. This shortcoming arises in part from the lack of effective treatments for st...
Eligibility Criteria
Inclusion
- 18 years of age and older
- identified in the Denver Health healthcare system who have had a methamphetamine-related encounter at Denver Health
Exclusion
- unable to complete the interview in English
- intoxicated or impaired and unable to consent to participate in the project and/or respond to the interview
- currently under residential involuntary psychiatric or substance treatment order (i.e., mental health hold, emergency commitment, or short-term certification)
- received any type of substance use treatment at DHHA in the last 90 days
- planning to enter substance treatment
- unable to complete the research visits in the next 90 days
Key Trial Info
Start Date :
April 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 29 2025
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT06033365
Start Date
April 11 2023
End Date
September 29 2025
Last Update
November 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Health
Denver, Colorado, United States, 80204